Accepted for Publication: August 11, 2013.
Published Online: November 18, 2013. doi:10.1001/jamainternmed.2013.11320.
Study concept and design: Anderson, Cox, Al-Khatib, Thomas, Fosbol, Peterson.
Acquisition of data: Anderson, Cox, Nichol, Eigel, Clendenen, Peterson.
Analysis and interpretation of data: Anderson, Cox, Al-Khatib, Nichol, Thomas, Chan, Saha-Chaudhuri, Fosbol, Clendenen, Peterson.
Drafting of the manuscript: Anderson.
Critical revision of the manuscript for important intellectual content: Cox, Nichol, Thomas, Chan, Saha-Chaudhuri, Fosbol, Eigel, Clendenen, Peterson.
Statistical analysis: Anderson, Cox, Saha-Chaudhuri, Fosbol, Peterson.
Obtained funding: Peterson.
Administrative, technical, and material support: Anderson, Eigel, Clendenen, Peterson.
Study supervision: Anderson, Nichol, Thomas, Saha-Chaudhuri, Peterson.
Conflict of Interest Disclosures: Dr Nichol reports being a board member for Medic One Foundation; being co–principal investigator for Resuscitation Outcomes Consortium and principal investigator for the Dynamic Automated External Defibrillator Registry (2010-2015); having received grants from the National Institutes of Health, the US Food and Drug Administration, Phillips Healthcare Inc, Physio-Control Inc, and Zoll Inc; and having received travel reimbursement from the American Heart Association (AHA). Dr Chan reports being a consultant for the AHA, Optum Rx, and Johnson & Johnson and having received a grant from the National Heart, Lung, and Blood Institute. Dr Eigel reports being an employee of the American Heart Association (AHA); as part of the AHA’s mission to improve cardiovascular health and reduce cardiovascular deaths, the AHA develops and sells CPR training books, videos, and online courses that generate revenue to further support the AHA mission. Mr Clendenen reports being the chief executive officer of and owning minority shares in the Health and Safety Institute. Dr Peterson reports serving as the principal investigator for the AHA Get With the Guidelines data analysis center. No other disclosures were reported.
Funding/Support: This study was supported by an award from the AHA–Pharmaceutical Roundtable (PRT) and by David and Stevie Spina.
Role of the Sponsor: The AHA-PRT and David and Stevie Spina had no role in the design and conduct of the study; in the collection, analysis, and interpretation of the data; or in the preparation, review, or approval of the manuscript.
Additional Contributions: Barbara Lytle, MS, Linda Davidson-Ray, MA, Vladimir Demyanenko, MS, and Erin LoFrese, MS, of the Duke Clinical Research Institute, John Thompson, BS, of the ARC, Steve Barnett, MBA, and Jeff Myers, BA, of the HSI, and Tim Williams, BA, of the AHA provided expertise and data support. They did not receive compensation for their contributions apart from employment at the institution where this study was conducted.